Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Acid Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104693092A reveals a one-step synthesis for PTP1B inhibitors. Discover cost reduction and supply chain advantages for high-purity pharmaceutical intermediates.
Patent CN117362252B details a bio-based furan route to FDCM. Offers safer Claisen reaction and scalable polymer intermediate production for global supply chains.
Novel isoxazoline preparation via Lewis acid catalysis. Mild conditions, high purity, cost-effective manufacturing for pharmaceutical intermediates.
Patent CN101717428A details a green synthesis of Budesonide using acidic ionic liquids. This report analyzes the technical breakthroughs, cost reduction potential, and supply chain reliability for pharmaceutical manufacturers.
Patent CN110606805A reveals a dual-synthesis route offering high purity and environmental compliance for global supply chains. This method ensures reliable availability of critical fine chemical intermediates for pharmaceutical applications.
Novel FeCl3-catalyzed route for polysubstituted N-arylpyrroles. High yield, mild conditions. Reliable pharmaceutical intermediate supplier for scalable production.
Novel dibromo-amino silica gel method achieves >99% selectivity and >99.8% purity for SGLT-2 inhibitors, significantly reducing waste and manufacturing costs.
Patent CN108530381B details a solvent-free method for diamine synthesis using saccharin. This offers significant cost reduction and supply chain reliability for API manufacturing.
Patent CN105777486B details a novel synthetic route for posaconazole intermediates offering reduced costs and enhanced supply chain reliability for global pharmaceutical manufacturers.
Patent CN115197139A reveals a green, high-yield route for Roxadustat intermediates. Discover cost-effective manufacturing and supply chain advantages.
Patent CN111484397B details a novel FeCl3 or I2 catalyzed one-pot synthesis for triarylmethane derivatives, enabling cost-effective manufacturing and reliable supply chain solutions.
Patent CN119241513B reveals green synthesis for antibacterial intermediates. Offers cost reduction and scalable supply chain solutions for pharmaceutical manufacturing.
Patent CN109134485B reveals a high-yield isosorbide synthesis using 1,4-sorbitan and solid acids. Discover cost-effective, scalable bio-based manufacturing solutions.
Patent CN107759472A reveals a high-yield synthetic route for Scutellarin intermediates, offering cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel 3-step synthesis for Dapagliflozin ensures high yield and purity. Cost-effective manufacturing solution for global pharmaceutical supply chains.
Patent CN101717320B details a green, one-pot Mannich base synthesis using water and liquid superacids. Discover cost-effective manufacturing and high-purity intermediates.
Novel CSA-catalyzed route offers high yield and room temperature operation for cost-effective pharmaceutical intermediate manufacturing and scalable production.
Patent CN104860897A reveals a novel Lewis acid catalyzed route for Hepatitis C intermediates. Achieve superior chiral purity and supply chain reliability with scalable manufacturing.
Patent CN102503887B reveals a mild AgOTf-catalyzed route to isoquinolines. This method offers cost reduction in API manufacturing and reliable supply chain solutions.
Novel Lewis acid catalyzed synthesis reduces reaction time significantly. High yield pharmaceutical intermediate production with scalable supply chain reliability for global partners.